|
1
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Floor S, van Staveren WC, Larsimont D,
Dumont JE and Maenhaut C: Cancer cells in epithelial-to-mesenchymal
transition and tumor-propagating-cancer stem cells: Distinct,
overlapping or same populations. Oncogene. 30:4609–4621. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gomes LR, Terra LF, Sogayar MC and
Labriola L: Epithelial-mesenchymal transition: Implications in
cancer progression and metastasis. Curr Pharm Biotechnol.
12:1881–1890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yao D, Dai C and Peng S: Mechanism of the
mesenchymal-epithelial transition and its relationship with
metastatic tumor formation. Mol Cancer Res. 9:1608–1620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A,
Siefker-Radtke A and Dinney C: Role of epithelial-to-mesenchymal
transition (EMT) in drug sensitivity and metastasis in bladder
cancer. Cancer Metastasis Rev. 28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi TP, Ma X, Fu B, Li H, Ai X, Xu H, Ju
Z, Wang C, Zhang G, Wang BJ and Zhang X: Expression of Notch
signaling in bladder cancer and its relationship with patients’
prognosis. Chin J Exp Surg. 9:1305–1307. 2010.In Chinese.
|
|
9
|
Wang Z, Li Y, Kong D and Sarkar FH: The
role of Notch signaling pathway in epithelial-mesenchymal
transition (EMT) during development and tumor aggressiveness. Curr
Drug Targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mills RD, Turner WH, Fleischmann A,
Markwalder R, Thalmann GN and Studer UE: Pelvic lymph node
metastases from bladder cancer: Outcome in 83 patients after
radical cystectomy and pelvic lymphadenectomy. J Urol. 166:19–23.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kamai T, Tsujii T, Arai K, Takagi K, Asami
H, Ito Y and Oshima H: Significant association of Rho/ROCK pathway
with invasion and metastasis of bladder cancer. Clin Cancer Res.
9:2632–2641. 2003.PubMed/NCBI
|
|
12
|
Ohashi S, Natsuizaka M, Naganuma S, Kagawa
S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D,
Gimotty PA, et al: A NOTCH3-mediated squamous cell differentiation
program limits expansion of EMT-competent cells that express the
ZEB transcription factors. Cancer Res. 71:6836–6847. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Espinoza I and Miele L: Notch inhibitors
for cancer treatment. Pharmacol Ther. 139:95–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishida T, Hijioka H, Kume K, Miyawaki A
and Nakamura N: Notch signaling induces EMT in OSCC cell lines in a
hypoxic environment. Oncol Lett. 6:1201–1206. 2013.PubMed/NCBI
|
|
15
|
Li Y, Ma J, Qian X, Wu Q, Xia J, Miele L,
Sarkar FH and Wang Z: Regulation of EMT by Notch signaling pathway
in tumor progression. Curr Cancer Drug Targets. 13:957–962. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schwanbeck R, Martini S, Bernoth K and
Just U: The Notch signaling pathway: Molecular basis of cell
context dependency. Eur J Cell Biol. 90:572–581. 2011. View Article : Google Scholar
|
|
17
|
Borggrefe T and Oswald F: The Notch
signaling pathway: Transcriptional regulation at Notch target
genes. Cell Mol Life Sci. 66:1631–1646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Capobianco AJ, Zagouras P, Blaumueller CM,
Artavanis-Tsakonas S and Bishop JM: Neoplastic transformation by
truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol.
17:6265–6273. 1997.PubMed/NCBI
|
|
19
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shun XD and Wang HZ: Research progress in
bladder cancer markers and its detection met hods. J Mod Urol.
17:319–321. 2012.
|
|
21
|
Gallahan D, Kozak C and Callahan R: A new
common integration region (int-3) for mouse mammary tumor virus on
mouse chromosome 17. J Virol. 61:218–220. 1987.PubMed/NCBI
|
|
22
|
Joshi I, Minter LM, Telfer J, Demarest RM,
Capobianco AJ, Aster JC, Sicinski P, Fauq A, Golde TE and Osborne
BA: Notch signaling mediates G1/S cell-cycle progression in T cells
via cyclin D3 and its dependent kinases. Blood. 113:1689–1698.
2009. View Article : Google Scholar :
|
|
23
|
Shi TP, Xu H, Wei JF, Ai X, Ma X, Wang BJ,
Ju ZH, Zhang GX, Wang C, Wu ZQ, Zhang X, et al: Association of low
expression of notch-1 and jagged-1 in human papillary bladder
cancer and shorter survival. J Urol. 180:361–366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng F and Wu G: The rejuvenated scenario
of epithelial-mesenchymal transition (EMT) and cancer metastasis.
Cancer Metastasis Rev. 31:455–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grego-Bessa J, Díez J, Timmerman L and de
la Pompa JL: Notch and epithelial-mesenchyme transition in
development and tumor progression: Another turn of the screw. Cell
Cycle. 3:718–721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leong KG, Niessen K, Kulic I, Raouf A,
Eaves C, Pollet I and Karsan A: Jagged1-mediated Notch activation
induces epithelial-to-mesenchymal transition through Slug-induced
repression of E-cadherin. J Exp Med. 204:2935–2948. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niessen K, Fu Y, Chang L, Hoodless PA,
McFadden D and Karsan A: Slug is a direct Notch target required for
initiation of cardiac cushion cellularization. J Cell Biol.
182:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sabbah M, Emami S, Redeuilh G, Julien S,
Prevost G, Zimber A, Ouelaa R, Bracke M, De Wever O and Gespach C:
Molecular signature and therapeutic perspective of the
epithelial-to-mesenchymal transitions in epithelial cancers. Drug
Resist Updat. 11:123–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shah AN, Summy JM, Zhang J, Park SI,
Parikh NU and Gallick GE: Development and characterization of
gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol.
14:3629–3637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Li Y, Kong D, Banerjee S, Ahmad A,
Azmi AS, Ali S, Abbruzzese JL, Gallick GE and Sarkar FH:
Acquisition of epithelial-mesenchymal transition phenotype of
gemcitabine-resistant pancreatic cancer cells is linked with
activation of the notch signaling pathway. Cancer Res.
69:2400–2407. 2009. View Article : Google Scholar : PubMed/NCBI
|
